comprehensive -WSS

comprehensive

author：leisure time 2025-09-03 03:39:21 - browse：717

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Steward Health Care has deal to sell doctor network to UnitedHealth

WSS

Scientists uncover potential path to treating deadly childhood tumor

The Readout: Lenmeldy, GLP

There's no autism epidemic. It's an autism diagnosis epidemic

Abortion pill Supreme Court ruling could impact entire drug industry

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Multiple sclerosis has subtypes with different best treatments: study

focus

comprehensive

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Roche subsidiary Foundation Medicine opens new headquarters

Guidelines to prevent youth baseball injuries need more muscle

Insurer loopholes limit power of law against surprise medical bills

Heart attack and stroke risk calculators need revising

Donor acceptance rates hint at racial, gender bias in heart transplants: study

The cancer drug shortage isn’t new — and neither are the solutions

Study: Black kids more likely to die after surgery than white kids

focus

Eliminate the waiting period for sterilization covered by Medicaid

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Eliminate the waiting period for sterilization covered by Medicaid

Why the world’s most expensive drug might be worth the price

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

focus

leisure time

leisure time

entertainment